The No. 1 Question Anyone Working In ADHD Medication Pregnancy Should Be Able To Answer
The No. 1 Question Anyone Working In ADHD Medication Pregnancy Should Be Able To Answer
Blog Article
ADHD Medication During Pregnancy and Breastfeeding
The decision to stop or continue ADHD medication during breastfeeding and pregnancy is challenging for women with the condition. There aren't many studies on how exposure to ADHD for a long time could affect the fetus.
A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality research.
Risk/Benefit Analysis
Women who are pregnant and taking ADHD medication must weigh the benefits of taking it versus the dangers for the foetus. The doctors don't have the information to make unambiguous recommendations but they can provide information on risks and benefits to help pregnant women make informed decisions.
A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during early pregnancy were not at a higher risk of fetal malformations or structural birth defects. Researchers conducted a massive population-based study of case control to assess the frequency of major structural defects in infants born to mothers who took stimulants during pregnancy. Pediatric cardiologists and clinical geneticists looked over the cases to ensure accurate classification of the cases and to reduce the possibility of bias.
The research conducted by the researchers was not without its limitations. The researchers were unable in the beginning to differentiate the effects triggered by the medication from the disorder. This limitation makes it difficult for researchers to determine if the small associations observed among the groups that were exposed to the use of medications, or if they were affected by comorbidities. In addition, the researchers did not look at the long-term effects of offspring on their parents.
The study showed that infants whose mother had taken ADHD medication during pregnancy had a slightly greater risk of being admitted to the neonatal care unit (NICU) in comparison to those whose mothers didn't take any medication during pregnancy or discontinued taking their medication prior to or during pregnancy. This was due to central nervous system-related disorders and the increased risk of admission was not found to be affected by the type of stimulant medications were used during pregnancy.
Women who took stimulant ADHD medication during pregnancy were also at an elevated chance of having a caesarean section or having a baby with an low Apgar score (less than 7). These increases did not appear to be affected by the type of medication that was used during pregnancy.
Researchers suggest that the minor risks associated with the use ADHD medications in early pregnancies could be offset by the greater benefits for mother and baby from continuing treatment for the woman's condition. Doctors should discuss with their patients about this issue and, if possible, help them improve coping skills which can lessen the impact of her disorder in her daily life and relationships.
Medication Interactions
As more women than ever before are being diagnosed with ADHD and being treated with medication, the dilemma of whether to keep or discontinue treatment during pregnancy is a question that doctors are having to confront. These decisions are usually taken without clear and authoritative evidence. Instead, doctors must consider their own expertise and experience, as well as the experiences of other doctors and the research that has been conducted on the subject.
The issue of potential risks to infants is difficult to determine. Many of the studies on this topic are based on observations rather than controlled research, and their conclusions are often contradictory. Additionally, the majority of studies limit their analysis to live births, which can underestimate the severity of teratogenic effects that could lead to abortion or termination of the pregnancy. The study discussed in the journal club addresses these issues by analyzing the data from deceased and live births.
Conclusion A few studies have shown a positive correlation between ADHD medications and certain birth defects however, other studies haven't established a link. Most studies show an unintended, or somewhat negative, impact. In all cases an in-depth study of the benefits and risks is required.
It isn't easy, but not impossible, for women with ADHD to stop taking their medication. In a recent piece published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of loneliness. Additionally, the loss of medication may affect the ability to perform job-related tasks and drive safely which are essential aspects of daily life for many people with ADHD.
She suggests that women who are not sure whether to take the medication or stop it due to their pregnancy should educate family members, colleagues, and acquaintances about the condition, the effects on daily functioning, and the benefits of continuing the current treatment. In addition, educating them can make the woman feel more comfortable in her struggle with her decision. It is important to remember that some medications are able to pass through the placenta, so if a woman decides to stop her ADHD medication during pregnancy and breastfeeding, she must be aware that the effects of the drug can be passed on to the baby.
Risk of Birth Defects
As the use and abuse of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases the concern over the possible effects of the drugs on fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of information on this topic. Utilizing two huge data sets, researchers were able to analyze more than 4.3 million pregnancies and determine whether the use of stimulant medications increased the risk of birth defects. Although the risk overall remains low, the scientists found that exposure in the first trimester to ADHD medications was linked to an increased risk of certain heart defects such as ventriculo-septal defect (VSD).
The authors of the study could not discover any link between early medication usage and other congenital anomalies, like facial deformities or club feet. The results are in agreement with previous studies which showed the existence of a slight, but significant increase in cardiac malformations for women who began taking ADHD medication prior to the time of the time of pregnancy. This risk increased during the latter part of pregnancy, when many women begin to discontinue their ADHD medication.
Women who took ADHD medications in the first trimester of their pregnancy were also more likely to undergo caesarean sections, a low Apgar score after delivery and a baby who needed breathing assistance during birth. However the authors of the study were not able to eliminate bias due to selection by restricting the study to women who didn't have any other medical issues that could be a click here contributing factor to these findings.
The researchers hope their study will serve to inform the clinical decisions of physicians who encounter pregnant women. They advise that while the discussion of the risks and benefits is crucial, the decision to stop or maintain medication should be based on each woman's requirements and the severity of her ADHD symptoms.
The authors also warn that even though stopping the medication is an option, it isn't an option that is recommended due to the high rate of depression and other mental health issues among women who are pregnant or who are recently post-partum. Further, the research suggests that women who choose to stop taking their medications are more likely to have difficulties adjusting to life without them following the birth of their baby.
Nursing
It can be a challenge to become a mom. Women with ADHD who have to manage their symptoms while attending physician appointments, getting ready for the arrival of a child and getting used to new routines at home can experience severe challenges. As such, many women choose to continue taking their ADHD medications throughout pregnancy.
The majority of stimulant medicines are absorbed through breast milk in small amounts, so the risk for infant who is breastfeeding is low. However, the rate of exposure to medications by the newborn may differ based on the dosage, frequency it is taken and at what time the medication is administered. Additionally, individual medications enter the infant's system differently through the gastrointestinal tract as well as breast milk, and the effect of this on a newborn is not yet fully understood.
Some physicians may discontinue stimulant medication during a woman’s pregnancy due to the absence of research. This is a difficult choice for the patient, who must weigh the benefits of keeping her medication against the potential dangers to the embryo. Until more information is available, doctors should inquire with all pregnant patients about their history of ADHD and whether they are planning or taking to take medication during the perinatal period.
Numerous studies have demonstrated that women can continue to take their ADHD medication safely during pregnancy and breast-feeding. As a result, more and more patients choose to do so and in consultation with their doctor they have discovered that the benefits of maintaining their current medication far outweigh any potential risks.
It is crucial for women suffering from ADHD who are thinking of breastfeeding to seek out a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss their medication with their prescriber as well as the pros and cons for continuing treatment. This includes non-pharmacological methods. Psychoeducation should also be offered to help pregnant women suffering from ADHD recognize their symptoms and underlying disorder Learn about the available treatment options and strengthen existing coping strategies. This should be an approach that is multidisciplinary, including the GP, obstetricians and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother as well as the child, as well as monitoring for signs of deterioration and, if needed, adjustments to the medication regimen.